Trends in health expectancies: a systematic review of international evidence.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
25 05 2021
Historique:
entrez: 26 5 2021
pubmed: 27 5 2021
medline: 1 6 2021
Statut: epublish

Résumé

A clear understanding of whether increases in longevity are spent in good health is necessary to support ageing, health and care-related policy. We conducted a systematic review to update and summarise evidence on trends in health expectancies, in Organisation for Economic Co-operation and Development (OECD) high-income countries. Four electronic databases (MEDLINE, 1946-19 September 2019; Embase 1980-2019 week 38; Scopus 1966-22 September 2019, Health Management Information Consortium, 1979-September 2019), and the UK Office for National Statistics website (November 2019). English language studies published from 2016 that reported trends in healthy, active and/or disability-free life expectancy in an OECD high-income country. Records were screened independently by two researchers. Study quality was assessed using published criteria designed to identify sources of bias in studies reporting trends, and evidence summarised by narrative synthesis. Twenty-eight publications from 11 countries were included, covering periods from 6 to 40 years, between 1970 and 2017. In most countries, gains in healthy and disability-free life expectancy do not match the growth in total life expectancy. Exceptions were demonstrated for women in Sweden, where there were greater gains in disability-free years than life expectancy. Gains in healthy and disability-free life expectancy were greater for men than women in most countries except the USA (age 85), Japan (birth), Korea (age 65) and Sweden (age 77). An expansion of disability in later life is evident in a number of high-income countries, with implications for the sustainability of health and care systems. The recent COVID-19 pandemic may also impact health expectancies in the longer term.

Identifiants

pubmed: 34035101
pii: bmjopen-2020-045567
doi: 10.1136/bmjopen-2020-045567
pmc: PMC8154999
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e045567

Subventions

Organisme : Medical Research Council
ID : MR/K02325X/1
Pays : United Kingdom
Organisme : The Dunhill Medical Trust
ID : RPGF1806/44
Pays : United Kingdom

Informations de copyright

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Popul Health Metr. 2016 Jul 12;14:23
pubmed: 27408607
Health Aff (Millwood). 2016 Aug 1;35(8):1351-8
pubmed: 27503957
Lancet. 2016 Oct 8;388(10053):1603-1658
pubmed: 27733283
Scand J Public Health. 2017 Jul;45(5):520-527
pubmed: 28381119
J Korean Med Sci. 2016 Nov;31 Suppl 2:S139-S145
pubmed: 27775251
Am J Public Health. 2016 Jun;106(6):1079-85
pubmed: 26985619
Lancet Public Health. 2018 Sep;3(9):e447-e455
pubmed: 30174210
Eur J Public Health. 2016 Oct;26(5):794-799
pubmed: 27085191
Health Promot Chronic Dis Prev Can. 2017 Mar;37(3):68-76
pubmed: 28273034
J Epidemiol Community Health. 2021 Jan 19;:
pubmed: 33468602
Eur J Public Health. 2019 Feb 1;29(1):82-87
pubmed: 29917065
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Arch Public Health. 2019 Feb 14;77:6
pubmed: 30815257
Lancet Public Health. 2017 May 23;2(7):e307-e313
pubmed: 28736759
Int J Public Health. 2019 Nov;64(8):1173-1181
pubmed: 31473783
Am J Public Health. 2018 Dec;108(12):1652-1658
pubmed: 30359113
Scand J Public Health. 2017 Jun;45(4):459-462
pubmed: 28539109
Int J Public Health. 2017 Jun;62(5):531-540
pubmed: 28239745
Lancet. 2018 Nov 10;392(10159):1859-1922
pubmed: 30415748
Eur J Public Health. 2016 Dec;26(6):1069-1074
pubmed: 27175003
Lancet. 2017 Oct 7;390(10103):1676-1684
pubmed: 28821408
Am J Public Health. 2016 Jul;106(7):1287-93
pubmed: 27077352
JAMA. 2002 Dec 25;288(24):3137-46
pubmed: 12495394
Lancet. 2016 Feb 20;387(10020):779-86
pubmed: 26680218
Int J Public Health. 2016 Sep;61(7):739-49
pubmed: 27349481
BMC Res Notes. 2016 Oct 28;9(1):482
pubmed: 27793196
J Korean Med Sci. 2018 Nov 02;34(Suppl 1):e88
pubmed: 30923491
Lancet. 2017 Sep 16;390(10100):1260-1344
pubmed: 28919118
Scand J Public Health. 2018 Feb;46(1):124-131
pubmed: 29191110

Auteurs

Gemma F Spiers (GF)

Population & Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK gemma-frances.spiers@newcastle.ac.uk.

Tafadzwa Patience Kunonga (TP)

Population & Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Fiona Beyer (F)

Population & Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Dawn Craig (D)

Population & Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Barbara Hanratty (B)

Population & Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Carol Jagger (C)

Population & Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH